Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2004-03-01 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75020), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE 43 : revenue, balance sheet and financial ratios
PHARMACIE 43 is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75020),
this company of category PME
shows in 2015 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE 43 (SIREN 452211659)
Indicator
2017
2016
2015
Revenue
N/C
N/C
1 608 774 €
Net income
45 360 €
-2 915 €
29 487 €
EBITDA
N/C
N/C
74 528 €
Net margin
N/C
N/C
1.8%
Revenue and income statement
In 2017, PHARMACIE 43 generates positive net income of 45 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2017: 29 k€ -> 45 k€.
Net income (2017)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
45 360 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 48%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2017)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
48.367%
Financial autonomy (2017)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
54.64%
Asset age ratio (2017)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
Debt ratio
59.932
53.03
48.367
Financial autonomy
55.296
53.531
54.64
Repayment capacity
12.443
None
None
Cash flow / Revenue
2.47%
None%
None%
Sector positioning
Debt ratio
48.372017
2015
2016
2017
Q1: 44.05
Med: 128.21
Q3: 288.79
Good
In 2017, the debt ratio of PHARMACIE 43 (48.37) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
54.64%2017
2015
2016
2017
Q1: 20.07%
Med: 35.54%
Q3: 55.67%
Good-7 pts over 3 years
In 2017, the financial autonomy of PHARMACIE 43 (54.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
12.44 years2015
2015
Q1: 2.13 years
Med: 6.76 years
Q3: 11.7 years
Average
In 2015, the repayment capacity of PHARMACIE 43 (12.44) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 133.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2017)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
133.594
Liquidity indicators evolution PHARMACIE 43
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
Liquidity ratio
163.677
117.365
133.594
Interest coverage
31.245
None
None
Sector positioning
Liquidity ratio
133.592017
2015
2016
2017
Q1: 115.53
Med: 157.08
Q3: 219.27
Average-22 pts over 3 years
In 2017, the liquidity ratio of PHARMACIE 43 (133.59) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
31.25x2015
2015
Q1: 6.08x
Med: 13.88x
Q3: 23.76x
Excellent
In 2015, the interest coverage of PHARMACIE 43 (31.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 911 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1608 days. Excellent situation: suppliers finance 697 days of the operating cycle (retail model).
Operating WCR (2017)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2017)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
911 j
Supplier credit (2017)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1608 j
Inventory turnover (2017)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE 43
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
Operating WCR
170 031 €
0 €
0 €
Inventory turnover (days)
23
0
0
Customer payment term (days)
22
675
911
Supplier payment term (days)
32
1403
1608
Positioning of PHARMACIE 43 in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 82 transactions of similar company sales
in 2017,
the value of PHARMACIE 43 is estimated at
514 922 €
(range 372 945€ - 715 103€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2017
82 tx
372k€514k€715k€
514 922 €Range: 372 945€ - 715 103€
NAF 5 année 2017
Valuation method used
Net Income Multiple
45 360 €
×
11.4x
=514 922 €
Range: 372 945€ - 715 104€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 82 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE 43 with other companies in the same sector:
Yes, PHARMACIE 43 generated a net profit of 45 k€ in 2017.
Where is the headquarters of PHARMACIE 43 ?
The headquarters of PHARMACIE 43 is located in PARIS (75020), in the department Paris.
Where to find the tax return of PHARMACIE 43 ?
The tax return of PHARMACIE 43 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE 43 operate?
PHARMACIE 43 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart